Somatropin

7 trials 2 recruiting HEndocrinology

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

2 Recruiting

4 Completed trials

5 Sponsors

18 Countries

Phase III

Phase II

Phase III: 5 Phase II: 2

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Sponsors using this IMP

Novo Nordisk A/S 3 Ascendis Pharma Endocrinology Division A/S 1 Medical University Of Vienna 1 Universitair Ziekenhuis Antwerpen 1 University College London 1

All trials

7 total

The OMNIMARA Trial Pending

2024-519935-41-00 Phase III 1 country Universitair Ziekenhuis Antwerpen
A Phase 3 Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children with Short Statur… Recruiting

2025-523079-44-00 Phase III 5 countries Ascendis Pharma Endocrinology Division A/S
InvestiGating the rOle of Growth Hormone in hepatic lipid metabolism in humans Recruiting

2024-518214-11-01 Phase II 1 country Medical University Of Vienna
A research study to compare somapacitan once a week with Norditropin® once a day in children who need help to grow Ended

2023-506927-27-00 Phase III 16 countries Novo Nordisk A/S
A research study in children born small and who stayed small. Treatment is somapacitan once a week compared to Norditropin® once a day Ended

2023-506830-66-00 Phase II 5 countries Novo Nordisk A/S
NIHR127468 - The GHD Reversal Trial Ended

2022-502008-62-00 Phase III 1 country University College London
A research study in children with low level of hormone to grow. Treatment is somapacitan once a week compared to Norditropin® once a day Ended

2023-506829-11-00 Phase III 8 countries Novo Nordisk A/S

Showing 1–7 of 7 trials

← All drugs A–Z